Bentley Capital Limited

BEL

Bentley Capital Ltd is a AU-based company operating in industry. The company is headquartered in Perth, Western Australia. Bentley Capital Limited is an Australia-based investment company. The firm's primary objective is to generate absolute returns for the benefit of its shareholders. The company is focused on investing its capital into emerging companies with capital growth potential. The company generally take a substantial equity stake in selected companies and targets a small number of investments within the portfolio. The firm's segments include Investments and Corporate. The Investments segment comprises securities listed on the Australian Securities Exchange (ASX), units in unlisted managed funds and other liquid financial assets. The Corporate segment provides corporate assets and operations. The company is focused on investing in various sectors, such as resources, energy, technology and services.

Bendigo and Adelaide Bank Limited

BEN

Bendigo & Adelaide Bank Ltd. engages in banking and financial services including consumer, residential, business, rural and commercial lending, deposit-taking, payments and foreign exchange services, wealth management, margin lending, and superannuation, and treasury. The company is headquartered in Bendigo, Victoria and currently employs 4,777 full-time employees. The firm is engaged in the provision of a range of banking and other financial services, including consumer, residential, business, rural and commercial lending, deposit-taking, payments services, wealth management, margin lending, and others. The Consumer division focuses on engaging with and servicing its consumer customers and includes the branch network, Up digital bank, mobile relationship managers, third party banking channels, wealth services, Homesafe, and customer support functions. The Business and Agribusiness segment focuses on servicing business customers and includes Business Banking, Portfolio Funding and Rural Bank, which includes all banking services provided to agribusiness, rural and regional Australian communities. The Corporate segment includes its support functions including treasury, technology, cards and payments, property services, strategy, finance and others.

Birddog Technology Limited

BDT

BirdDog Technology Ltd. develops and manufactures audio-visual and video technology. The principal activities of the Company consist of development and manufacturing of global video technology that enhances the quality, speed and flexibility of video through a range of solutions, augmented with network device interface (NDI). These solutions are then sold through a network of distributors and resellers and direct, to individuals and organizations within professional video, corporate audio-visual (AV) and digital signage markets who demand broadcast quality video content. The Company’s product portfolio includes converters, camera lines, AV section, software, and accessories. The Company’s NDI Bridge transports complete NDI streams over local area network (LAN), wide area network (WAN) or public Internet. Its NDI Audio Direct makes audio-over-IP available for software-based audio applications.

Bcal Diagnostics Limited

BDX

BCAL Diagnostics Ltd. develops screening tests for the early detection of breast cancer. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-07-21. The Company’s core activity is the development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer, which is available to all women. The company is developing diagnostic technology to assist in the early detection of breast cancer by identifying, measuring and validating specific biomarkers enriched in the patient’s blood. The company is engaged in the research and development of non-invasive diagnostic technologies designed to complement existing imaging technologies, such as the mammogram. Its BCAL laboratory employs liquid chromatography mass spectrometry (LCMS) platforms to build on the Company's clinical research and leverage progress. The Company’s BCAL test is a lipid biomarker blood (Breast Cancer Associated Lipids test) test with the potential to be used for breast cancer prevention, screening, and monitoring.